Evidence map›Paper›PMID 22495673›Full record

ArticleEndocrinology2012

Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.

Jesse J Parry, Ronald Chen, Rebecca Andrews, Kimberly A Lears, Buck E Rogers

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Plasticity in ligand recognition at somatostatin receptors.Nature structural & molecular biology · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jesse J ParryDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63108-8224, USA.
Ronald Chen
Rebecca Andrews
Kimberly A Lears
Buck E Rogers
Washington University in St. Louis · US

Funding

Somatostatin Receptor Based PET Imaging of Gene TransferR01EB004533 · NIBIB · WASHINGTON UNIVERSITY · PI ROGERS, BUCK E. · 2005 to 2008
$1.2M
NIBIB NIH HHS R01 EB004533NIBIB NIH HHS R01 EB04533
6 · The paper itself

Abstract

G protein signaling through human somatostatin receptor subtype 2 (SSTR2) is well known, but the amino acids involved in stimulation of intracellular responses upon ligand binding have not been characterized. We constructed a series of point mutants in SSTR2 at amino acid positions 89, 139, and 140 in attempts to disrupt G protein signaling upon ligand binding. The aspartic acid changes at position 89 to either Ala, Leu, or Arg generated mutant receptors with varying expression profiles and a complete inability to bind somatostatin-14 (SST). Mutations to Asp 139 and Arg 140 also led to varying expression profiles with some mutants maintaining their affinity for SST. Mutation of Arg 140 to Ala resulted in a mutated receptor that had a B(max) and dissociation constant (K(d)) similar to wild-type receptor but was still coupled to the G protein as determined in both a cAMP assay and a calcium-release assay. In contrast, mutation of Asp 139 to Asn resulted in a mutated receptor with B(max) and K(d) values that were similar to wild type but was uncoupled from G protein-mediated cAMP signaling, but not calcium release. Thus, we identified mutations in SSTR2 that result in either receptor expression levels that are similar to wild type but is completely ablated for ligand binding or a receptor that maintains affinity for SST and is uncoupled from G protein-mediated cAMP signaling.

Indexed as

Signal TransductionAlanineAmino AcidsAmino Acid SubstitutionArginineAspartic AcidBinding, CompetitiveBinding SitesCalciumCell Line, TumorCyclic AMPFluorescent Antibody TechniqueGene ExpressionGTP-Binding ProteinsHumansKineticsAlanineAmino AcidsArginineAspartic AcidCalciumCyclic AMPGTP-Binding ProteinsLeucineReceptors, SomatostatinSomatostatinsomatostatin receptor 2

Identifiers

PMID22495673
PMCPMC3359596
OpenAlexW2010789544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.